Vetter starts construction of new facility in Germany for production of injectable drugs
Singapore, May 14 -- Vetter, a leading Contract Development and Manufacturing Organization (CDMO), has announced the start of construction on its new site in Saarlouis with a traditional groundbreaking ceremony. During the first construction phase, the company will build a state-of-the-art facility for the commercial production of injectable drugs on the 95-acre industrial site.
In total, Vetter will invest almost half a billion euros in the site by the planned commissioning in 2031, underscoring its role as an industry leader for quality and technology. Once operational, the facility will create 400 to 500 new jobs, a figure that could rise to 1,500 by the final stage of the first construction phase. Ultimately, up to 2,000 jobs could b...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.